Pages that link to "Q24242605"
Jump to navigation
Jump to search
The following pages link to Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants (Q24242605):
Displaying 30 items.
- Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants (Q24188100) (← links)
- Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants (Q24197958) (← links)
- Paracetamol (acetaminophen) for patent ductus arteriosus in preterm and/or low-birth-weight infants (Q24201052) (← links)
- Role of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practice (Q24631088) (← links)
- Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse (Q30439920) (← links)
- Safety and effectiveness of indomethacin versus ibuprofen for treatment of patent ductus arteriosus (Q33879390) (← links)
- Patent ductus arteriosus in premature neonates (Q35607990) (← links)
- Risk Factors and Clinical Outcomes in Preterm Infants with Pulmonary Hypertension (Q36157625) (← links)
- Anesthesia and Analgesia in the NICU (Q36730497) (← links)
- Effect of oral ibuprofen on patent ductus arteriosus in premature newborns (Q37055663) (← links)
- Drugs of choice for sedation and analgesia in the neonatal ICU. (Q37144585) (← links)
- Patent arterial duct (Q37276609) (← links)
- Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? (Q37698200) (← links)
- The management of evolving bronchopulmonary dysplasia (Q37778597) (← links)
- Improved Closure of Patent Ductus Arteriosus With High Doses of Ibuprofen (Q37981592) (← links)
- Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review (Q38239124) (← links)
- Patent ductus arteriosus in preterm infant: Basic pathology and when to treat (Q38919316) (← links)
- Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs in Neonates (Q38974176) (← links)
- The renal adverse effects of ibuprofen are not mediated by AQP2 water channels (Q43100540) (← links)
- Ibuprofen in very preterm infants impairs renal function for the first month of life. (Q43245134) (← links)
- Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus. (Q46219964) (← links)
- Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants (Q57688747) (← links)
- Isoprostane levels in urine of preterm newborns treated with ibuprofen for patent ductus arteriosus closure (Q58188406) (← links)
- Indomethacin therapy for patent ductus arteriosus in premature infants (Q81053110) (← links)
- Bronchopulmonary dysplasia: clinical practices in five Portuguese neonatal intensive care units (Q84146340) (← links)
- Global shortage and rationing of indomethacin: need to refine approach (Q84318735) (← links)
- Prevention of bronchopulmonary dysplasia (Q84525024) (← links)
- Indomethacin vs ibuprofen: comparison of efficacy in the setting of conservative therapeutic approach (Q85855312) (← links)
- Drug Closure of a Patent Ductus Arteriosus in An Extremely Low Birth Weight Premature Newborn. A Case Report (Q89395794) (← links)
- Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants (Q89657621) (← links)